fbpx

State lawmakers and prescription drugs

This year, state lawmakers across the U.S. have introduced an unprecedented 160 bills to stem the rising cost of prescription drugs, and have enacted 37 into law.

States are pursuing a range of strategies to tackle drug costs including;

  • allowing pharmacists to share lower cost drug options with consumers,
  • enacting laws that authorize the wholesale purchase of drugs from Canada,
  • and requiring drug manufacturers to provide additional data justifying price increases over specified thresholds.

For the past several years there has been increased interest and activity on legislation that relates to the pricing, payment, and costs associated with prescription drugs. Can more be done?

We conducted a survey amongst 4842 M3 Global Research members in Canada and the United States asking them:

"Should State legislators do more to curb the rising cost of prescription drugs?"

Both countries share similar opinions, you can find below what the M3 Global Research community answered to this question.

By registering with M3 Global Research you will receive the Monthly Pulse directly to your inbox and you will be able to share your opinion about relevant healthcare related issue and compare your thoughts with your colleagues around the World.

2 comments

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.